New White Paper: Charting the Landscape of Real-World Data in the U.S.

New White Paper: Charting the Landscape of Real-World Data in the U.S.

1 min read
Learn how real-world data is transforming U.S. healthcare and life sciences. Our new white paper maps datasets, applications, challenges, and future directions.

Real-world data (RWD) is reshaping healthcare and life sciences by filling gaps left by traditional clinical trials and enabling more evidence-based decisions. From regulatory review to value-based care, RWD provides insights that reflect real patient populations and everyday clinical practice.

That’s why we developed Charting the Landscape of Real-World Data in the U.S.—a comprehensive white paper that maps the most widely used U.S. datasets, demonstrates how they’re applied across healthcare, and explores solutions to challenges around access, quality, and interoperability.

Why Real-World Data Matters

Randomized clinical trials (RCTs) remain the gold standard for establishing safety and efficacy, but they don’t capture the full complexity of care in real-world settings. RWD helps close that gap.

Collected from electronic health records (EHRs), insurance claims, registries, and digital health tools, RWD reflects the diversity of patient experiences. When rigorously analyzed, it becomes real-world evidence (RWE), offering critical insights into long-term outcomes, safety, and therapeutic opportunities.

Today, RWD is no longer an optional supplement. It is central to healthcare innovation, regulatory science, and clinical practice.

What’s Inside the White Paper

You’ll find a clear, practical guide that covers:

  • Core concepts of RWD and RWE
  • The most commonly used U.S. datasets and what they capture
  • Applications across life sciences and healthcare
  • Challenges in leveraging RWD and how to address them
  • Best practices and future directions shaping the field

Grounded in a targeted literature review and 27 expert interviews, the paper offers both high-level perspective and actionable insights.

Who Should Read This?

This white paper is designed for professionals across the healthcare ecosystem:

  • Researchers and life sciences leaders expanding the evidence base and advancing R&D
  • Clinicians working to improve patient outcomes and care delivery
  • Data strategists and health tech innovators building next-generation solutions

Regardless of your role, this paper offers practical guidance for navigating and leveraging RWD effectively.

Get Your Copy Today

The future of healthcare will be built on the responsible, intelligent use of real-world data—accelerating research, driving innovation, and improving outcomes.

Other Posts You Might Like

Budget Impact Models: A Practical Tool for Healthcare Decision-Making
Budget Impact Models: A Practical Tool for Healthcare Decision-Making
Oct 07, 2025
Learn how Budget Impact Models help payers and HTA agencies assess short-term affordability of new healthcare treatments alongside cost-effectiveness analysis....
Read more
Chart showing global vaccine trial trends
Polygon Health Analytics Launches Vaccine Trial Atlas: Making Clinical Trial Data Accessible
Sep 16, 2025
The vaccine research and development community has faced unprecedented challenges in recent months, including policy upheavals, leadership changes, research program cancellations, and a surge of misinformation...
Read more
Launchpad
Polygon Health Analytics Celebrates Graduation of 2025 Launchpad Cohort
Sep 03, 2025
[Philadelphia, September 2, 2025] – Polygon Health Analytics proudly announces the successful graduation of its 2025 Launchpad Program cohort—the second since the program’s inception—marking...
Read more
Patient_Reported_With_Doctor
Patient-Reported Outcomes: Bringing the Patient’s Voice into Clinical Development and Outcomes Research
Aug 14, 2025
When it comes to healthcare, numbers and lab results only tell part of the story. What about how patients feel? How treatments impact their daily lives?...
Read more
Powerful AI Starts with High-Quality Data: Lessons from Edwin Chen and Surge AI
Powerful AI Starts with High-Quality Data: Lessons from Edwin Chen and Surge AI
Jul 28, 2025
In a world where AI headlines are dominated by billion-dollar fundraises, massive model sizes, and compute power arms races, Edwin Chen offers a refreshing counter-narrative. As...
Read more
Understanding Health Technology Assessment (HTA): A Strategic Imperative for Innovators
Understanding Health Technology Assessment (HTA): A Strategic Imperative for Innovators
Jul 15, 2025
If you're a scientist transitioning into the biotechnology sector or an entrepreneur developing a novel therapy for an unmet medical need, one term will...
Read more
Literature Reviews
Systematic Literature Reviews and AI: A Gold Standard Meets Innovation
Jun 01, 2025
Discover how Systematic Literature Reviews (SLRs) provide a gold-standard method for evidence synthesis in biomedicine—and how AI is transforming the process. Learn the key steps, differences from other review types, and the future potential of automation in research....
Read more
Perfect timing
No Perfect Timing: Embracing Uncertainty in Business and Life
Apr 16, 2025
"Is now the right time?" It’s a question I hear often—from aspiring entrepreneurs, working parents, and close friends. Whether it’s starting...
Read more
Calling for Lupus Patients and Caregivers to Shape the Future of Lupus Care
Calling for Lupus Patients and Caregivers to Shape the Future of Lupus Care
Mar 11, 2025
Sponsored by the National Institute of Minority Health and Health Disparities (NIMHD), Polygon Health Analytics is iSMILE (Individualized Social Risk Management in Systemic Lupus Erythematosus Care)...
Read more
AI_Life_Science
Is Life Science Ready for AI?
Jan 01, 2025
A few days ago, Dr. Geoffrey Hinton, often referred to as the “Godfather of AI,” made a chilling statement: “There is a 10-20 percent probability that...
Read more
View all